VistaGen Therapeutics, Inc. Contracts & Agreements

Amendment No. 4 to Consulting Agreement by and between the Company and FitzPatirck Co. LLC, dated November 9, 2023 (Filed With SEC on November 9, 2023)

Underwriting Agreement, dated as of October 2, 2023, by and among the Company, Jefferies LLC, Stifel, Nicolaus & Company, Incorporated and William Blair & Company, L.L.C (Filed With SEC on October 4, 2023)

Form of Pre-Funded Warrant (Filed With SEC on October 4, 2023)

Form of T1 Warrant (Filed With SEC on October 4, 2023)

Form of T2 Warrant (Filed With SEC on October 4, 2023)

Exclusive Negotiation Agreement by and between Fuji Pharma Co., Ltd. and Vistagen Therapeutics, Inc., dated September 1, 2023 (Filed With SEC on September 8, 2023)

Amendment No 3. to Consulting Services Agreement between Vistagen Therapeutics, Inc. and FitzPatrick & Co. LLC effective July 1, 2023 (Filed With SEC on June 28, 2023)

Consulting Services Agreement between Vistagen Therapeutics, Inc. and Mark Smith, dated November 16, 2022 (Filed With SEC on June 28, 2023)

Amendment No. 1 to Master Services Agreement by and between Vistagen Therapeutics, Inc. and Allucent, dated June 24, 2022 (Filed With SEC on June 28, 2023)

Amendment No 2. to Consulting Services Agreement between Vistgen Therapeutics, Inc. and FitzPatrick & Co. LLC effective January 1, 2023 (Filed With SEC on February 7, 2023)

Agreement and Plan of Merger, by and among Vistagen Therapeutics, Inc., VTGN Merger Sub, Inc., Pherin Pharmaceuticals, Inc., and Kevin McCarthy, dated December 20, 2022 (Filed With SEC on December 21, 2022)

Consulting Services Agreement between Vistagen Therapeutics, Inc and FitzPatrick & Co. LLC, dated January 21, 2022 (Filed With SEC on November 10, 2022)

Amendment No, 1 to Consulting Services Agreement between Vistagen Therapeutics, Inc and FitzPatrick & Co. LLC, effective June 1, 2022 (Filed With SEC on November 10, 2022)

Consulting Agreement between Vistagen Therapeutics, Inc and i3 Strategy, dated November 10, 2022 (Filed With SEC on November 10, 2022)

Indemnification Agreement, dated May 13, 2022, by and between VistaGen Therapeutics, Inc. and Reid G. Adler J.D (Filed With SEC on August 11, 2022)

Third Amendment to Lease, by and between Bayside Area Development, LLC and VistaGen Therapeutics, Inc. dated October 14, 2021 (Filed With SEC on November 10, 2021)

Indemnification Agreement, dated July 21, 2021, by and between VistaGen Therapeutics, Inc. and Margaret M. FitzPatrick (Filed With SEC on July 22, 2021)

Indemnification Agreement, dated July 6, 2021, by and between VistaGen Therapeutics, Inc. and Mary L. Rotunno J.D (Filed With SEC on July 8, 2021)

Open Market Sale AgreementSM, dated May 14, 2021, by and between VistaGen Therapeutics, Inc. and Jefferies LLC (Filed With SEC on May 14, 2021)

Underwriting Agreement, dated December 18, 2020, by and among VistaGen Therapeutics, Inc., Jefferies LLC and William Blair & Company, L.L.C (Filed With SEC on December 22, 2020)

License and Collaboration Agreement, by and between VistaGen Therapeutics, Inc. and EverInsight Therapeutics Inc., dated June 24, 2020 (Filed With SEC on August 13, 2020)

Underwriting Agreement, dated August 2, 2020, by and between VistaGen Therapeutics, Inc. and Maxim Group LLC (Filed With SEC on August 6, 2020)

License and Collaboration Agreement, by and between VistaGen Therapeutics, Inc. and EverInsight Therapeutics Inc., dated June 24, 2020 (Filed With SEC on June 26, 2020)

Form of Securities Purchase Agreement, dated January 24, 2020, between the Company and each purchaser named in the signature pages thereto (Filed With SEC on January 27, 2020)

Form of Warrant (Filed With SEC on January 27, 2020)

Form of Subscription Agreement for Fall 2019 Private Placement (Filed With SEC on November 7, 2019)

Indemnification Agreement, dated November 10, 2016, by and between VistaGen Therapeutics, Inc. and Mark A. McPartland (Filed With SEC on June 25, 2019)

Master Services Agreement, dated July 11, 2017, by and between VistaGen Therapeutics, Inc. and Cato Research Ltd (Filed With SEC on June 25, 2019)

Underwriting Agreement, dated February 26, 2019, by and between VistaGen Therapeutics, Inc. and William Blair & Company, L.L.C (Filed With SEC on March 4, 2019)

Indemnification Agreement, dated January 10, 2019, by and between VistaGen Therapeutics, Inc. and Ann Cunningham (Filed With SEC on January 15, 2019)

License Agreement (PH10), by and between VistaGen Therapeutics, Inc. and Pherin Pharmaceuticals, Inc., dated October 24, 2018 (Filed With SEC on October 29, 2018)

Form of Fall 2018 Private Placement Subscription Agreement (Filed With SEC on October 29, 2018)

Form of Fall 2018 Private Placement Warrant (Filed With SEC on October 29, 2018)

License Agreement, by and between VistaGen Therapeutics, Inc. and Pherin Pharmaceuticals, Inc., dated September 11, 2018 (Filed With SEC on September 13, 2018)

Option Agreement, by and between VistaGen Therapeutics, Inc. and Pherin Pharmaceuticals, Inc., dated September 11, 2018 (Filed With SEC on September 13, 2018)

Form of 2018 Private Placement Subscription Agreement (Filed With SEC on August 9, 2018)

Form of 2018 Private Placement Warrant (Filed With SEC on August 9, 2018)

Underwriting Agreement, dated December 11, 2017 (Filed With SEC on December 13, 2017)

Form of Warrant (Filed With SEC on December 13, 2017)

Form of Underwriting Agreement (Filed With SEC on December 7, 2017)

Form of Warrant (Filed With SEC on December 7, 2017)

Underwriting Agreement, dated as of August 31, 2017,by and between VistaGen Therapeutics, Inc. and Oppenheimer & Co. Inc (Filed With SEC on August 31, 2017)

Form of Series A1 Warrant (Filed With SEC on August 31, 2017)

Form of Series A2 Warrant (Filed With SEC on August 31, 2017)

VISTAGENTHERAPEUTICS, INC. AMENDEDAND RESTATED 2016STOCK INCENTIVE PLAN (formerly,the 2008 Stock Incentive Plan) (Filed With SEC on June 29, 2017)

EXCLUSIVE LICENSEAND SUBLICENSE AGREEMENT by andbetween VISTAGENTHERAPEUTICS, INC. and APOLLOBIOLOGICS LP EXCLUSIVE LICENSEAND SUBLICENSE AGREEMENT (Filed With SEC on February 13, 2017)

R E C I T A L S : (Filed With SEC on November 14, 2016)

VISTAGEN THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on June 24, 2016)

Second Amendment to Employment Agreement (Filed With SEC on June 24, 2016)

VistaGen Therapeutics, Inc. (Filed With SEC on May 16, 2016)

VISTAGEN THERAPEUTICS, INC. WARRANT AGENCY AGREEMENT (Filed With SEC on May 16, 2016)

COMMON STOCK PURCHASE WARRANT VISTAGEN THERAPEUTICS, INC. (Filed With SEC on May 16, 2016)

VistaGen Therapeutics, Inc. _____ shares of Common Stock Warrants to purchase up to [_____] shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 5, 2016)

COMMON STOCK PURCHASE WARRANT VISTAGEN THERAPEUTICS, INC. (Filed With SEC on May 5, 2016)

VISTAGEN THERAPEUTICS, INC. WARRANT AGENCY AGREEMENT (Filed With SEC on May 5, 2016)

WARRANT EXCHANGE AGREEMENT (Filed With SEC on February 16, 2016)

AGREEMENT (Filed With SEC on May 13, 2015)

ACKNOWLEDGEMENT AND AGREEMENT (Filed With SEC on May 13, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 13, 2015)

AMENDMENT NO. 2 (Filed With SEC on October 3, 2014)

AMENDMENT NO. 1 TO AMENDED AND RESTATED NOTE CONVERSION AGREEMENT AND WARRANT AMENDMENT (Filed With SEC on September 4, 2014)

Form of Subscription Agreement (Filed With SEC on July 28, 2014)

FORM OF WARRANT TO PURCHASE SHARES OF COMMON STOCK OF VISTAGEN THERAPEUTICS, INC. Expires August __, 201_ (Filed With SEC on July 28, 2014)

FORM OF PLACEMENT AGENCY AGREEMENT _____________, 2014 (Filed With SEC on July 28, 2014)

FORM OF ESCROW DEPOSIT AGREEMENT (Filed With SEC on July 28, 2014)

AMENDED AND RESTATED NOTE CONVERSION AGREEMENT AND WARRANT AMENDMENT (Filed With SEC on July 22, 2014)

SUBSCRIPTIONAGREEMENT UNITS (Filed With SEC on June 25, 2014)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on June 25, 2014)

WARRANT TO PURCHASE COMMON STOCK OF VISTAGEN THERAPEUTICS, INC. (Filed With SEC on June 25, 2014)

AMENDMENT TO CONVERTIBLE PROMISSORY NOTE AND WARRANT (Filed With SEC on June 25, 2014)

PROMISSORY NOTE (Filed With SEC on June 25, 2014)

WARRANT TO PURCHASE COMMON STOCK OF VISTAGEN THERAPEUTICS, INC. (Filed With SEC on June 25, 2014)

SUBSCRIPTION AGREEMENT (Filed With SEC on April 8, 2014)

VISTAGEN THERAPEUTICS, INC. (Filed With SEC on April 8, 2014)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF VISTAGEN THERAPEUTICS, INC. Expires December 31, 2016 (Filed With SEC on April 8, 2014)

VISTAGEN THERAPEUTICS, INC. Senior Secured Convertible Promissory Note (Filed With SEC on August 2, 2013)

SERIES 2012 WARRANT TO PURCHASE SHARES OF COMMON STOCK OF VISTAGEN THERAPEUTICS, INC. Expires July 26, 2018 (Filed With SEC on August 2, 2013)

ASSIGNMENTANDASSUMPTION AGREEMENT (Filed With SEC on July 18, 2013)

BRITANNIA MODULAR LABS I LEASE (Filed With SEC on July 18, 2013)

VISTAGEN THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on July 18, 2013)

AMENDMENT NO. 2 TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 28, 2013)

AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 1, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 10, 2013)

VISTAGEN THERAPEUTICS, INC. VOTING AGREEMENT (Filed With SEC on April 10, 2013)

NOTE CONVERSION AGREEMENT (Filed With SEC on April 10, 2013)

AMENDMENT NO. 2 TO NOTE EXCHANGE AND PURCHASE AGREEMENT (Filed With SEC on February 14, 2013)

NOTE EXCHANGE AND PURCHASE AGREEMENT Dated as of October 11, 2012 By and Between VISTAGEN THERAPEUTICS, INC. and PLATINUM LONG TERM GROWTH VII, LLC (Filed With SEC on October 16, 2012)

VISTAGEN THERAPEUTICS, INC. Senior Secured Convertible Promissory Note (Filed With SEC on October 16, 2012)

SERIES 2012 WARRANT TO PURCHASE SHARES OF COMMON STOCK OF VISTAGEN THERAPEUTICS, INC. Expires _______ ___, 20__ (Filed With SEC on October 16, 2012)

AMENDED AND RESTATED SECURITY AGREEMENT (Filed With SEC on October 16, 2012)

INTELLECTUAL PROPERTY SECURITY AND STOCK PLEDGE AGREEMENT (Filed With SEC on October 16, 2012)

NEGATIVE COVENANT AGREEMENT (Filed With SEC on October 16, 2012)

LICENSE AGREEMENT NUMBER 2 dated as of March 19,2012 between UNIVERSITY HEALTH NETWORK (as "Licensor") and VISTAGEN THERAPEUTICS, INC. (as "Licensee") (Filed With SEC on July 2, 2012)

EXCHANGE AGREEMENT (Filed With SEC on July 2, 2012)

VISTAGEN THERAPEUTICS, INC. Secured Convertible Promissory Note (Filed With SEC on July 2, 2012)

SECURITY AGREEMENT (Filed With SEC on July 2, 2012)

Notice of Award (Filed With SEC on December 20, 2011)

SIGN AND RETURN THIS PAGE TO CIRMRT1-01012-1 NOTICE OF GRANT AWARD CIRM RFA-08-02:Tools & Technologies California Institute for Regenerative Medicine (Filed With SEC on December 20, 2011)

AGREEMENT AND PLAN OF MERGER EXCALIBER ENTERPRISES, LTD., EXCALIBER MERGER SUBSIDIARY, INC. AND VISTAGEN THERAPEUTICS, INC. (Filed With SEC on May 16, 2011)

VISTAGEN THERAPEUTICS, INC. FOURTH AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT (Filed With SEC on May 16, 2011)

VISTAGEN, INC. 1999 STOCK INCENTIVE PLAN (Filed With SEC on May 16, 2011)

VISTAGEN, THERAPEUTICS, INC. 1999 STOCK INCENTIVE PLAN NOTICE OF STOCK OPTION AWARD (Filed With SEC on May 16, 2011)

VISTAGEN, INC. SCIENTIFIC ADVISORY BOARD 1998 STOCK INCENTIVE PLAN NOTICE OF STOCK OPTION AWARD (Filed With SEC on May 16, 2011)

VISTAGEN THERAPEUTICS, INC. 2008 STOCK INCENTIVE PLAN (Filed With SEC on May 16, 2011)

VISTAGEN THERAPEUTICS, INC. (Filed With SEC on May 16, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 16, 2011)

WITNESSETH: (Filed With SEC on May 16, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 16, 2011)

Shawn K. Singh, JD Chief Executive Officer VistaGen Therapeutics, Inc. 384 Oyster Point Blvd., No. 8 South San Francisco, CA 94080 ###-###-#### ***@*** (Filed With SEC on May 16, 2011)

VISTAGEN, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on May 16, 2011)

VISTAGEN THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on May 16, 2011)

Industrial Lease Oyster Point Business Park South San Francisco, California Shelton International Holdings, Inc., a Hawaii corporation, as Landlord, and Vistagen Therapeutics,... (Filed With SEC on May 16, 2011)

CLINICAL STUDY AGREEMENT IND 75,807 AV-101 (Filed With SEC on May 16, 2011)

STRATEGIC DEVELOPMENT SERVICES AGREEMENT (Filed With SEC on May 16, 2011)

LICENSE AGREEMENT (Filed With SEC on May 16, 2011)

AGREEMENT BETWEEN MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY AND VISTAGEN THERAPEUTICS, INC. LICENSE AGREEMENT (Filed With SEC on May 16, 2011)

NON-EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on May 16, 2011)

SPONSORED RESEARCH COLLABORATION AGREEMENT By and Between University Health Network, an Ontario corporation and (Filed With SEC on May 16, 2011)

LICENSE AGREEMENT between UNIVERSITY OF MARYLAND, BALTIMORE and CORNELL RESEARCH FOUNDATION, INC, and ARTEMIS NEUROSCIENCE, INC, (Filed With SEC on May 16, 2011)

NON-EXCLUSIVE LICENSE AGREEMENT FOR INTERNAL PHARMACEUTICAL RESEARCH (Filed With SEC on May 16, 2011)

VISTAGEN THERAPEUTICS, INC. Amended and Restated Senior Convertible Promissory Bridge Note (Filed With SEC on May 16, 2011)

UNSECURED PROMISSORY NOTE (Filed With SEC on May 16, 2011)

UNSECURED PROMISSORY NOTE CDN$502,796.79 Issuance Date: May 5,2011 (Filed With SEC on May 16, 2011)

UNSECURED PROMISSORY NOTE U.S. $2,200,000 Issuance Date: May 5, 2011 (Filed With SEC on May 16, 2011)

PROMISSORY NOTE $170,000.00 South San Francisco, California February 25, 2010 (Filed With SEC on May 16, 2011)

VISTAGEN THERAPEUTICS, INC. NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on May 16, 2011)

VISTAGEN THERAPEUTICS, INC. CONVERSION AGREEMENT (Filed With SEC on May 16, 2011)

AGREEMENT REGARDING CONVERSION OF UNSECURED PROMISSORY NOTE (Filed With SEC on May 16, 2011)

VISTAGEN THERAPEUTICS, INC. SENIOR CONVERTIBLE BRIDGE NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on May 16, 2011)

VISTAGEN THERAPEUTICS, INC.SENIOR CONVERTIBLE BRIDGE NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on May 16, 2011)

Executive Employment Agreement (Filed With SEC on May 16, 2011)

Amended and Restated Executive Employment Agreement (Filed With SEC on May 16, 2011)

AGREEMENT REGARDING SALE OF SHARES OF COMMON STOCK (Filed With SEC on May 16, 2011)

JOINDER AGREEMENT (Filed With SEC on May 16, 2011)

Category

Industry

Companies

Contracts

VistaGen Therapeutics, Inc. Contracts & Agreements